@prefix orcid: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" . sub:version prov:value "1"^^xsd:integer . rdf:object ns1:C0030705 "patients"; ns1:C0205210 "clinical"; ns1:C0231218 "ill"; ns1:C0282440 "randomized controlled trials"; ns1:C3272565 "clinical" . rdf:predicate ns3:TRIPLE_UID:gvu30egy-TRIPLE-ABSTRACT-1 "demonstrate" . rdf:subject ns1:C0011777 "dexamethasone"; ns1:C0087111 "treatments"; ns1:C4726677 "remdesivir" . rdfs:Triple-UID ns2:TRIPLE_UID:gvu30egy-TRIPLE-ABSTRACT-1 "gvu30egy-TRIPLE-ABSTRACT-1" . rdfs:sentence rdfs:label "To date, only two treatments, remdesivir and dexamethasone, have demonstrated clinical efficacy through randomized controlled trials (RCTs) in seriously ill patients." . rdfs:triple rdfs:label "only two treatments , remdesivir and dexamethasone demonstrated clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" . } sub:provenance { sub:assertion prov:generatedAtTime "2021-07-25T21:47:25.030430"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "en/IeyO2kZHD62n+EeTxDuNkIMXfD3MIMI+ZI/haVVNyx/CYegcTU3hiivwYkPnPsP76K4Lka80a1A+6XuLc9rdiPgHr7uV/GX5GlMe/DA+wWScbPlPlvmFmh7f84TxQQajg1a85HjKnpAA3IvISKLqe5noKN19IJwrRiC1pCls="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-07-25T21:47:25.030430"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-8954-0470 . }